Share on StockTwits

Vernalis plc (LON:VER)‘s stock had its “buy” rating reaffirmed by investment analysts at N+1 Singer in a note issued to investors on Thursday, Analyst RN reports. They currently have a GBX 42 ($0.71) price target on the stock. N+1 Singer’s target price indicates a potential upside of 20.00% from the company’s current price.

Shares of Vernalis plc (LON:VER) traded down 1.41% on Thursday, hitting GBX 35.00. 59,165 shares of the company’s stock traded hands. Vernalis plc has a 52 week low of GBX 18.668 and a 52 week high of GBX 38.125. The stock’s 50-day moving average is GBX 35.67 and its 200-day moving average is GBX 33.86.

A number of other firms have also recently commented on VER. Analysts at Edison Group reiterated a “positive” rating on shares of Vernalis plc in a research note on Monday, April 14th. Separately, analysts at Canaccord Genuity initiated coverage on shares of Vernalis plc in a research note on Tuesday, April 1st. They set a “buy” rating and a GBX 51 ($0.86) price target on the stock. Finally, analysts at Nplus1 Brewin reiterated a “buy” rating on shares of Vernalis plc in a research note on Tuesday, April 1st. They now have a GBX 43 ($0.72) price target on the stock.

Vernalis plc is a research and development-stage pharmaceutical company. Vernalis has one marketed product and a portfolio of development and drug discovery programmes.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.